About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The Psychiatry, Mental Health and Addictions Research Group at the Vall d'Hebron Research Institute is a multidisciplinary team that over the past 13 years has focused its scientific activity on the research (both nationally and internationally) of clinical, therapeutic and etiopathogenic aspects of:
At international level, it participates and/or coordinates several European projects of great repercussion in the area of mental health. At national level, it is part of the CIBERSAM (Centre for Biomedical Research in Mental Health Network) together with other leading groups, conducting research of excellence.
PMID: 33627840 Journal: MOLECULAR PSYCHIATRY Year: 2021 Reference: Mol Psychiatry. 2021 Jul;26(7):3663. doi: 10.1038/s41380-021-01049-6. Impact factor: 15.992 Publication type: Letter or abstract Authors: Franke, Barbara, Faraone, Stephen V, Casas, Miguel, Ramos-Quiroga, Josep Antoni, Ribases, Marta, Neale, Benjamin M, Borglum, Anders D, Vink, Jacqueline M, Stringer, Sven, Soler Artigas, Maria et al. DOI: 10.1038/s41380-021-01049-6
PMID: 33613322 Journal: Frontiers in Physiology Year: 2021 Reference: Front Physiol. 2021 Feb 5;12:628236. doi: 10.3389/fphys.2021.628236. eCollection 2021. Impact factor: 4.566 Publication type: Paper in international publication Authors: Rizzuto, Valeria, Koopmann, Tamara T, Blanco-Alvarez, Adoracion, Tazon-Vega, Barbara, Idrizovic, Amira, Diaz de Heredia, Cristina, Del Orbe, Rafael, Pampliega, Miriam Vara, Velasco, Pablo, Santen, Gijs W E et al. DOI: 10.3389/fphys.2021.628236
PMID: 33616199 Journal: REVISTA DE NEUROLOGIA Year: 2021 Reference: Rev Neurol. 2021 Mar 1;72(5):168-176. doi: 10.33588/rn.7205.2020639. Impact factor: 0.87 Publication type: Review in national publication Authors: Gomez-Barros, N, Ramos-Quiroga, J A, Vidal, R, Nieto-Fernandez, Z et al. DOI: 10.33588/rn.7205.2020639
PMID: 32281520 Journal: Transcultural Psychiatry Year: 2021 Reference: Transcult Psychiatry. 2021 Feb;58(1):126-139. doi: 10.1177/1363461520916697. Epub 2020 Apr 11. Impact factor: 2.221 Publication type: Paper in international publication Authors: Collazos, Francisco, Malagon-Amor, Angeles, Falgas-Bague, Irene, Qureshi, Adil, Gines, Jose Maria, Del Mar Ramos, Maria, McPeck, Samantha, Hussain, Isra, Wang, Ye, Alegria, Margarita et al. DOI: 10.1177/1363461520916697
The doctoral training program of excellence led by the UAB TOUCH MSCA-COFUND, focused on the field of mental health, opens its second call until March 31.
Irritability in ADHD and BDP is an understudied symptom that has a major impact on patients' quality of life and may even increase the risk of suicide.
These results reinforce the need for more individualized attention to address educational needs from an early stage.
